The abstract is read at the publisher; the summary is JClub's.
Fecal neuraminidase activity is linked to higher future Crohn’s disease risk in a prospective GEM cohort, with OR = 1.541 (95% CI: 1.05–2.25; p = 0.026).
- Why it matters: The study addresses how host–microbe interactions in early, preclinical Crohn’s disease may be captured by a functional gut readout tied to mucin barrier biology.
- What they did: In a matched set of 69 future CD cases and 69 healthy first-degree relative controls, fecal neuraminidase activity was measured by a fluorometric assay and tested with conditional logistic regression. It was then correlated with 446 serum proteins, fecal calprotectin, and gut microbiome composition from 16S rRNA sequencing.
- The result: Neuraminidase-associated proteins were enriched in immune and inflammatory pathways, and activity correlated with fecal calprotectin (p ≤ 0.05); adjusting for fecal calprotectin attenuated the CD-risk association. Fourteen microbial taxa correlated with neuraminidase activity (q ≤ 0.05), supporting its relevance to preclinical host–microbe alterations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.